Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076322
Filing Date
2015-11-05
Accepted
2015-11-05 17:16:59
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17826_110q.htm 10-Q 1104692
2 EX-31.1 a15-17826_1ex31d1.htm EX-31.1 11185
3 EX-31.2 a15-17826_1ex31d2.htm EX-31.2 11205
4 EX-32.1 a15-17826_1ex32d1.htm EX-32.1 5285
5 EX-32.2 a15-17826_1ex32d2.htm EX-32.2 5310
  Complete submission text file 0001104659-15-076322.txt   5066792

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gern-20150930.xml EX-101.INS 1296701
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20150930.xsd EX-101.SCH 30059
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20150930_cal.xml EX-101.CAL 40193
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20150930_def.xml EX-101.DEF 95420
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gern-20150930_lab.xml EX-101.LAB 315955
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20150930_pre.xml EX-101.PRE 207125
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 151201672
SIC: 2834 Pharmaceutical Preparations